GlassScriptPhysician profile
Michael A Vasquez
NPI 1841231511
$43,308.09
in general payments reported to CMS, 2019-2025
18 companies · $917 in 2025
The $917 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,381 · 2020: $3,708 · 2021: $99.29 · 2022: $2,956 · 2023: $106 · 2024: $27K · 2025: $917.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $19K · Travel and Lodging: $7,605 · Food and Beverage: $1,009 · Consulting Fee: $425.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $19,125.00 |
| Travel and Lodging | $7,604.52 |
| Food and Beverage | $1,009.23 |
| Consulting Fee | $425.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $29,681.06 | 2021-2025 | Venaseal |
| Tactile Systems Technology INC | $6,491.72 | 2019-2024 | Flexitouch Plus, Entre Plus |
| Medtronic Vascular, INC. | $5,509.87 | 2019-2020 | |
| Intuitive Surgical, INC. | $483.50 | 2022 | |
| Inari Medical, INC. | $453.25 | 2020-2022 | |
| Cook Medical LLC | $149.14 | 2025 | Zenith Alpha |
| Silk Road Medical, INC. | $137.62 | 2022 | |
| Biocompatibles, INC. | $108.50 | 2019 | |
| Revance Therapeutics, INC. | $104.75 | 2025 | Daxxify |
| E.R. Squibb & Sons, L.L.C. | $29.65 | 2021-2025 | Eliquis |
| Abbott Laboratories | $24.07 | 2022 | |
| Coloplast Corp | $22.69 | 2023 | |
| Edwards Lifesciences Corporation | $21.44 | 2022 | |
| Smith+Nephew, INC. | $21.27 | 2023 | Collagenase Santyl |
| Janssen Pharmaceuticals, INC | $18.88 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lemaitre Vascular, INC. | $18.18 | 2020 | |
| Organogenesis INC. | $16.35 | 2021 | |
| Bsn Medical INC | $16.15 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Vasquez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.